Abstract

BackgroundEculizumab is an orphan drug for Atypical Haemolytic Uremic Syndrome (aHUS). The disease is characterised by non-immune haemolytic anaemia, thrombocytopenia and renal impairment.PurposeTo assess the efficacy of eculizumab in adult...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Association between corneal arcus and some of the risk factors for coronary artery disease.
H Zauberman ... S Eisenberg
The British journal of ophthalmology | VOL. 67
H Zauberman, et. al.H Zauberman ... S Eisenberg
01 Dec 1983
Insights From the Use in Clinical Practice of Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome Affecting the Native Kidneys: An Analysis of 19 Cases
Maud Cousin ... Khair Rifard
American Journal of Kidney Diseases | VOL. 63
Maud Cousin, et. al.Maud Cousin ... Khair Rifard
08 Sep 2013
Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
Rupesh Raina ... Mohit Gupta
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy | VOL. 22
Rupesh Raina, et. al.Rupesh Raina ... Mohit Gupta
17 Dec 2017
Атипичный гемолитико-уремический синдром: современные представления о патогенезе, клинике, подходах к диагностике и лечению
Н.Л Козловская
Тромбоз, гемостаз и реология | VOL. -
Н.Л КозловскаяН.Л Козловская
28 Nov 2019
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
EAHP and GS1 publish report of UZ Leuven meeting on bedside scanning and medicines bar coding
Richard Price
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Richard PriceRichard Price
19 May 2014
In peer review we trust—or do we?
Phil Wiffen
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil WiffenPhil Wiffen
19 May 2014
European Parliament Committee approves €3 billion public-private partnership with industry on new medicine development
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
19 May 2014
Chapter 5: Appraising the evidence
Phil Wiffen ... Hao Lu
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil Wiffen, et. al.Phil Wiffen ... Hao Lu
19 May 2014
View more papers